188 related articles for article (PubMed ID: 11408510)
1. Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy.
Zanotti KM; Rybicki LA; Kennedy AW; Belinson JL; Webster KD; Kulp B; Peterson G; Markman M
J Clin Oncol; 2001 Jun; 19(12):3126-9. PubMed ID: 11408510
[TBL] [Abstract][Full Text] [Related]
2. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity.
Markman M; Zanotti K; Peterson G; Kulp B; Webster K; Belinson J
J Clin Oncol; 2003 Dec; 21(24):4611-4. PubMed ID: 14673050
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
Lee CW; Matulonis UA; Castells MC
Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759
[TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity reaction to carboplatin: successful resolution by replacement with cisplatin.
Porzio G; Marchetti P; Paris I; Narducci F; Ricevuto E; Ficorella C
Eur J Gynaecol Oncol; 2002; 23(4):335-6. PubMed ID: 12214738
[TBL] [Abstract][Full Text] [Related]
5. Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?
Syrigou E; Makrilia N; Vassias A; Nikolaidis I; Xyla V; Manolopoulos L; Syrigos K
Anticancer Drugs; 2010 Mar; 21(3):333-8. PubMed ID: 20038831
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin desensitization.
Choi J; Harnett P; Fulcher DA
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):137-41. PubMed ID: 15328672
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin hypersensitivity reactions: a single institution experience.
Zorzou MP; Efstathiou E; Galani E; Bozas G; Kastritis E; Papadimitriou C; Dimopoulos MA; Bamias A
J Chemother; 2005 Feb; 17(1):104-10. PubMed ID: 15828452
[TBL] [Abstract][Full Text] [Related]
8. Utility of delayed reading of intradermal test in carboplatin-induced drug hypersensitivity.
D'Amelio CM; Aramendía JM; Yuste JR; Fusco JP; Gastaminza G; Goikoetxea MJ
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):534-5. PubMed ID: 26021896
[No Abstract] [Full Text] [Related]
9. Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study.
Gomez R; Harter P; Lück HJ; Traut A; Kommoss S; Kandel M; du Bois A
Int J Gynecol Cancer; 2009 Oct; 19(7):1284-7. PubMed ID: 19823066
[TBL] [Abstract][Full Text] [Related]
10. Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity.
Rose PG; Fusco N; Smrekar M; Mossbruger K; Rodriguez M
Gynecol Oncol; 2003 Jun; 89(3):429-33. PubMed ID: 12798707
[TBL] [Abstract][Full Text] [Related]
11. Effect of Prophylactic Extended-Infusion Carboplatin on Incidence of Hypersensitivity Reactions in Patients with Ovarian, Fallopian Tube, or Peritoneal Carcinomas.
Pasternak AL; Link NA; Richardson CM; Rose PG
Pharmacotherapy; 2016 Jul; 36(7):723-30. PubMed ID: 27196693
[TBL] [Abstract][Full Text] [Related]
12. The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment.
O'Cearbhaill R; Zhou Q; Iasonos A; Hensley ML; Tew WP; Aghajanian C; Spriggs DR; Lichtman SM; Sabbatini PJ
Gynecol Oncol; 2010 Mar; 116(3):326-31. PubMed ID: 19944454
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin plus paclitaxel in the treatment of gynecologic malignancies: the Cleveland Clinic experience.
Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-26-S15-29. PubMed ID: 9346218
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions.
Markman M; Hsieh F; Zanotti K; Webster K; Peterson G; Kulp B; Spicel A; Belinson J
J Cancer Res Clin Oncol; 2004 Jan; 130(1):25-8. PubMed ID: 14564516
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum.
Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
J Clin Oncol; 2001 Apr; 19(7):1901-5. PubMed ID: 11283121
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity reactions to intraperitoneal administration of carboplatin in ovarian cancer: the first report of a case.
Shukunami K; Kurokawa T; Kawakami Y; Kubo M; Kotsuji F
Gynecol Oncol; 1999 Mar; 72(3):431-2. PubMed ID: 10053120
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer.
Gadducci A; Tana R; Teti G; Zanca G; Fanucchi A; Genazzani AR
Int J Gynecol Cancer; 2008; 18(4):615-20. PubMed ID: 18754135
[TBL] [Abstract][Full Text] [Related]
18. Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma.
Ottaiano A; Tambaro R; Greggi S; Prato R; Di Maio M; Esposito G; Scala F; Barletta E; Losito S; De Vivo R; Iaffaioli VR; Pignata S
Anticancer Res; 2003; 23(4):3465-8. PubMed ID: 12926091
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin hypersensitivity: evaluation and successful desensitization protocol.
Bruchim I; Goldberg A; Fishman A; Confino-Cohen R
Immunotherapy; 2014; 6(8):905-12. PubMed ID: 25313569
[TBL] [Abstract][Full Text] [Related]
20. Relationship between a history of systemic allergic reactions and risk of subsequent carboplatin hypersensitivity.
Markman M; Zanotti K; Kulp B; Peterson G; Markman M
Gynecol Oncol; 2003 Jun; 89(3):514-6. PubMed ID: 12798720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
